MSAT Engineer
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Drug Product Manufacturing Science and Technology Engineer to join our MSAT team, supporting our internal and external manufacturing sites. In this role, you will lead technology transfer and solve process issues in current good manufacturing practice (cGMP) operations while collaborating with multi-functional teams, Manufacturing, and Strategic Sourcing.
Job description
Build our future together
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Drug Product Manufacturing Science and Technology Engineer to join our MSAT team, supporting our internal and external manufacturing sites. In this role, you will lead technology transfer and solve process issues in current good manufacturing practice (cGMP) operations while collaborating with multi-functional teams, Manufacturing, and Strategic Sourcing.
When & where
Where: East Greenbush, NY, United States. Shift: Monday-Friday, 8-4:30pm. Travel: 10-50% domestic, sometimes international.
Discover your role
- Provide drug product process knowledge for new product introduction, technology transfer, validation, and troubleshooting
- Act as technical lead for technology transfer, tracking milestones from procurement to process transfer
- Review, approve, and author cGMP batch records, validation protocols, and technical reports
- Trend process performance, review process data, and provide floor support during operations
- Assist with deviation investigations, root cause determination, and corrective and preventive action (CAPA)
- Support equipment selection, qualification, and start-up, and partner with Strategic Sourcing on vendor delivery
- Support sampling plans, regulatory filings, information requests, inspections, and audits
- Continuously seek improvements throughout all stages of the process
This role requires
- Bachelors in Engineering or related field
- Engineer: Requires BS/BA in an engineering related field with 2+ years of proven experience in a pharmaceutical/biologics cGMP manufacturing, MSAT, process development, or analytical environment; or MS with 0-1+ years; or equivalent combination of education and experience
- Experience with siRNA, AAVs, LNPs, ADCs, and protein therapeutics is a plus
- Proven technical knowledge of aseptic and biopharmaceutical drug product manufacturing, product development, and validation
- Experience working with Contract Manufacturing Organizations is preferred
Requirements
- Bachelors in Engineering or related field
- BS/BA in an engineering related field with 2+ years of proven experience in a pharmaceutical/biologics cGMP manufacturing, MSAT, process development, or analytical environment; or MS with 0-1+ years; or equivalent combination of education and experience
- Proven technical knowledge of aseptic and biopharmaceutical drug product manufacturing, product development, and validation
- Experience with siRNA, AAVs, LNPs, ADCs, and protein therapeutics is a plus
- Experience working with Contract Manufacturing Organizations is preferred
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.